Research Analysts’ Updated EPS Estimates for March 4th (ACAD, ANF, CORZ, CRVO, CRWD, ERE.UN, EYPT, GLDD, HOTH, ICFI)

Research Analysts’ updated eps estimates for Wednesday, March 4th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its target price raised by JPMorgan Chase & Co. from $31.00 to $34.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Abercrombie & Fitch (NYSE:ANF) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $125.00 target price on the stock.

Abercrombie & Fitch (NYSE:ANF) had its target price trimmed by Jefferies Financial Group Inc. from $135.00 to $130.00. Jefferies Financial Group Inc. currently has a buy rating on the stock.

Core Scientific (NASDAQ:CORZ) had its price target raised by Canaccord Genuity Group Inc. from $17.00 to $20.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.

CervoMed (NASDAQ:CRVO) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $31.00 price target on the stock.

CrowdStrike (NASDAQ:CRWD) had its price target boosted by DA Davidson from $425.00 to $455.00. They currently have a buy rating on the stock.

European Residential Real Estate Investment Trust (TSE:ERE.UN) was downgraded by analysts at Desjardins from a hold rating to a tender rating. They currently have C$1.90 price target on the stock, up from their previous price target of C$1.20.

Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its price target boosted by Chardan Capital from $27.00 to $29.00. The firm currently has a buy rating on the stock.

Great Lakes Dredge & Dock (NASDAQ:GLDD) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $17.00 target price on the stock.

Hoth Therapeutics (NASDAQ:HOTH) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $5.00 price target on the stock.

ICF International (NASDAQ:ICFI) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $102.00 price target on the stock.

Kohl’s (NYSE:KSS) had its market perform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $23.00 price target on the stock.

Pet Valu (TSE:PET) was downgraded by analysts at Canadian Imperial Bank of Commerce from an outperform rating to a neutral rating. Canadian Imperial Bank of Commerce currently has C$28.00 price target on the stock, down from their previous price target of C$36.00.

Pet Valu (TSE:PET) was downgraded by analysts at National Bank Financial from an outperform rating to a sector perform rating. The firm currently has C$28.00 target price on the stock, down from their previous target price of C$37.00.

Pinterest (NYSE:PINS) had its neutral rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $20.00 target price on the stock.

Real Brokerage (NASDAQ:REAX) had its buy rating reiterated by analysts at JonesTrading. They currently have a $5.00 price target on the stock.

Stitch Fix (NASDAQ:SFIX) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $6.00 target price on the stock.

Silver Standard Resources (NASDAQ:SSRM) (TSE:SSO) was upgraded by analysts at Bank of America Corporation from an underperform rating to a buy rating.

Thor Industries (NYSE:THO) had its target price lowered by DA Davidson from $102.00 to $100.00. They currently have a neutral rating on the stock.

Receive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.